259 related articles for article (PubMed ID: 17617901)
1. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.
Forceville X; Laviolle B; Annane D; Vitoux D; Bleichner G; Korach JM; Cantais E; Georges H; Soubirou JL; Combes A; Bellissant E
Crit Care; 2007; 11(4):R73. PubMed ID: 17617901
[TBL] [Abstract][Full Text] [Related]
2. Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study--selenium and sepsis.
Forceville X
J Trace Elem Med Biol; 2007; 21 Suppl 1():62-5. PubMed ID: 18039501
[TBL] [Abstract][Full Text] [Related]
3. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
[TBL] [Abstract][Full Text] [Related]
4. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
[TBL] [Abstract][Full Text] [Related]
5. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial].
Lindner D; Lindner J; Baumann G; Dawczynski H; Bauch K
Med Klin (Munich); 2004 Dec; 99(12):708-12. PubMed ID: 15599680
[TBL] [Abstract][Full Text] [Related]
8. Delayed increase of plasma selenoproteins and absence of side effect induced by infusion of pharmacological dose of sodium selenite in septic shock: Secondary analysis of a multicenter, randomized controlled trial.
Forceville X; Laviolle B; Gromadzinska J; Boutten A; Van Antwerpen P; Plouvier E; Annane D; Bellissant E;
J Trace Elem Med Biol; 2022 Sep; 73():127031. PubMed ID: 35793609
[TBL] [Abstract][Full Text] [Related]
9. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*.
Bernard GR; Francois B; Mira JP; Vincent JL; Dellinger RP; Russell JA; Larosa SP; Laterre PF; Levy MM; Dankner W; Schmitt N; Lindemann J; Wittebole X
Crit Care Med; 2014 Mar; 42(3):504-11. PubMed ID: 24335445
[TBL] [Abstract][Full Text] [Related]
11. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
[TBL] [Abstract][Full Text] [Related]
12. [Pharmaconutrition with parenteral selenium in sepsis].
Langlois PL; de Oliveira Figliolino LF; Hardy G; Manzanares W
Med Intensiva; 2014 Apr; 38(3):173-80. PubMed ID: 24021703
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose sodium selenite in cardiac surgery patients: A randomized controlled bi-center trial.
Schmidt T; Pargger H; Seeberger E; Eckhart F; von Felten S; Haberthür C
Clin Nutr; 2018 Aug; 37(4):1172-1180. PubMed ID: 28502744
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.
Mishra V; Baines M; Perry SE; McLaughlin PJ; Carson J; Wenstone R; Shenkin A
Clin Nutr; 2007 Feb; 26(1):41-50. PubMed ID: 17174015
[TBL] [Abstract][Full Text] [Related]
15. Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients: The SUSTAIN CSX Randomized Clinical Trial.
Stoppe C; McDonald B; Meybohm P; Christopher KB; Fremes S; Whitlock R; Mohammadi S; Kalavrouziotis D; Elke G; Rossaint R; Helmer P; Zacharowski K; Günther U; Parotto M; Niemann B; Böning A; Mazer CD; Jones PM; Ferner M; Lamarche Y; Lamontagne F; Liakopoulos OJ; Cameron M; Müller M; Zarbock A; Wittmann M; Goetzenich A; Kilger E; Schomburg L; Day AG; Heyland DK;
JAMA Surg; 2023 Mar; 158(3):235-244. PubMed ID: 36630120
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
18. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
[TBL] [Abstract][Full Text] [Related]
19. SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX-trial): study design of an international multicenter randomized double-blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients.
Stoppe C; McDonald B; Rex S; Manzanares W; Whitlock R; Fremes S; Fowler R; Lamarche Y; Meybohm P; Haberthür C; Rossaint R; Goetzenich A; Elke G; Day A; Heyland DK
Trials; 2014 Aug; 15():339. PubMed ID: 25169040
[TBL] [Abstract][Full Text] [Related]
20. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
Annane D; Sébille V; Bellissant E;
Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
